3.2 Assessing the risk of cyanotoxin intake
and breakthrough in drinking-water abstraction and treatment
So far, you have dealt with assessing the risk of cyanobacterial
proliferation in the water-body. As a result, you
have either identified a risk of occurrence that you wish to address with
appropriate control measures, or you found that you could not exclude such a
risk. Therefore, to protect public health from cyanotoxins in drinking-water,
it is important to assess the efficacy of further barriers potentially in place
through your offtake strategy or drinking-water treatment system.
If bank filtration / soil
passage is in place, please assess its characteristics: example for filling in this table
For this
assessment, including hydrogeological expertise in the team is recommended. For
further information click
here.
|
|
Y |
P |
N |
? |
Your assessment of the
situation |
Uncertainty of your
assessment |
|
Substrate oxidised ? |
|
|
|
|
|
|
|
Travel time > 4 weeks |
|
|
|
|
||
|
Substrate fine-grained |
|
|
|
|
||
|
Temperatures > 10 °C |
|
|
|
|
||
|
Accumulation of
lysing cyanobacterial cells on the sediment likely to be low |
|
|
|
|
||
|
….. |
|
|
|
|
Y = yes
P = partially
If the raw water source is a reservoir, where is the offtake located ? example for filling in this table
For this
assessment, including expertise in reservoir management is recommended.
|
|
Y |
P |
N |
? |
Your assessment of the
situation |
Uncertainty of this
assessment |
|
Is offtake depth
and/or site variable ? |
|
|
|
|
|
|
|
Are water layers used for offtake
continuously monitored for indication of cyanobacterial cells (e.g. by
on-line turbidity- or fluorescence recording)? |
|
|
|
|
||
|
Is variability of offtake
sufficient to avoid layers with cyanobacteria? |
|
|
|
|
||
|
….. |
|
|
|
|
Y = yes
P = partially
Which treatment steps are
implemented at the treatment plant ? example for filling in this table
For this assessment,
including expertise in drinking-water treatment is recommended.
|
|
Y |
P |
N |
? |
Your assessment of the
situation |
Uncertainty of this
assessment |
|
No[c1] pre-oxidation, or under control for lysis and
liberation of dissolved toxin |
|
|
|
|
|
|
|
Flocculation |
|
|
|
|
||
|
Filtration |
|
|
|
|
||
|
Post-oxidation |
|
|
|
|
||
|
Dosing powdered activated carbon (PAC) |
|
|
|
|
||
|
Granular
carbon filtration (GAC) |
|
|
|
|
||
|
….. |
|
|
|
|
Y = yes
P = partially
Back to è START
[c1]Pre-oxidation risks damaging cells, i.e. inducing lysis and toxin
release without providing sufficient oxidation potential for toxin degradation.
This may constitute a risk, which is why “no“ should be entered here if pre-oxidation
is being practiced.